Predictors of Hemorrhage Following Intra-Arterial Thrombolysis for Acute Ischemic Stroke: The Role of Pial Collateral Formation

被引:107
作者
Christoforidis, G. A. [1 ]
Karakasis, C.
Mohammad, Y. [3 ]
Caragine, L. P. [2 ]
Yang, M.
Slivka, A. P. [3 ]
机构
[1] Ohio State Univ, Med Ctr, Coll Med, Dept Radiol, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Neurosurg, Coll Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Neurol, Coll Med, Columbus, OH 43210 USA
关键词
TISSUE-PLASMINOGEN-ACTIVATOR; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; PROACT II; TRANSFORMATION; THERAPY; RECANALIZATION; HYPERGLYCEMIA; RISK;
D O I
10.3174/ajnr.A1276
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND AND PURPOSE: The extent of pial collateral formation during acute ischemic stroke has been shown to influence outcomes. This study examines whether angiographic assessment of pial collateral formation is predictive of hemorrhagic transformation following intra-arterial thrombolysis (IAT) for acute ischemic stroke. MATERIALS AND METHODS: Rates of any hemorrhage and significant hemorrhage >25 mL) were reviewed in 104 consecutive patients who underwent IAT following acute ischemic stroke. The influence of the anatomic extent of pial collateral formation on the rates of hemorrhage and significant hemorrhage relative to known predictors for hemorrhagic transformation (presenting systolic blood pressure, blood glucose level, platelet level, and National Institutes of Health Stroke Scale [NIHSS] score, history of diabetes, time to treatment, age, sex, occlusion site, and extent of reperfusion) was analyzed by using logistic regression models. RESULTS: Rates of any hemorrhage and significant hemorrhage were 25.2% (26/104) and 9.7% (10/104), respectively. The rate of significant hemorrhage was 25.0% (8/32) in patients with poor pial collaterals and 2.78% (2/72) in those with good pial collaterals (P = .0004, Pearson correlation). The rate of any hemorrhage was also significantly higher in patients with poor pial collaterals (40.6% versus 18.1%; P = .0142, Pearson correlation), Logistic regression analyses revealed that pial collateral formation (odds ratio [OR] = 3.04), history of diabetes (OR = 4.83), platelets <200,000/mu L (OR = 2.95), and time to treatment <3 hours (OR = 12.0) were statistically significant predictors of hemorrhage, whereas pial collateral formation (OR = 13 1) and platelets <200,000/mu L (OR = 8.1) were statistically significant predictors of significant hemorrhage. CONCLUSIONS: Poor pial collateral formation is associated with higher incidence and larger size of hemorrhage following IAT.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 29 条
[11]   Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia [J].
Gasche, Y ;
Copin, JC ;
Sugawara, T ;
Fujimura, M ;
Chan, PH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (12) :1393-1400
[12]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[13]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[14]  
Hamann Gerhard F., 1999, Thrombosis and Haemostasis, V82, P92
[15]   Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke [J].
Higashida, RT ;
Furlan, AJ .
STROKE, 2003, 34 (08) :E109-E137
[16]   Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke - The PROACT II trial [J].
Kase, CS ;
Furlan, AJ ;
Wechsler, LR ;
Higashida, RT ;
Rowley, HA ;
Hart, RG ;
Molinari, GF ;
Frederick, LS ;
Roberts, HC ;
Gebel, JM ;
Sila, CA ;
Schulz, GA ;
Roberts, RS ;
Gent, M .
NEUROLOGY, 2001, 57 (09) :1603-1610
[17]   Hyperglycemia and the vascular effects of cerebral ischemia [J].
Kawai, N ;
Keep, RF ;
Betz, AL .
STROKE, 1997, 28 (01) :149-154
[18]   Revascularization end points in stroke interventional trials - Recanalization versus reperfusion in IMS-I [J].
Khatri, P ;
Neff, J ;
Broderick, JP ;
Khoury, JC ;
Carrozzella, J ;
Tomsick, T .
STROKE, 2005, 36 (11) :2400-2403
[19]   Intracranial hemorrhage associated with revascularization therapies [J].
Khatri, Pooja ;
Wechsler, Lawrence R. ;
Broderick, Joseph P. .
STROKE, 2007, 38 (02) :431-440
[20]   Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis [J].
Kidwell, CS ;
Saver, JL ;
Carneado, J ;
Sayre, J ;
Starkman, S ;
Duckwiler, G ;
Gobin, YP ;
Jahan, R ;
Vespa, P ;
Villablanca, JP ;
Liebeskind, DS ;
Vinuela, F .
STROKE, 2002, 33 (03) :717-724